5.1
Strong Sell
Sentiment
-1.00
Impact
0.50
Momentum
-0.04
Fundamentals
+0.00
Volume
1.00

IMP

Dược phẩm Imexpharm

Dược phẩm Y tế 📰 1 News →
56
-0.18%
Market Cap: 1.5T

News Sentiment

Articles Analyzed
3
Dominant Sentiment
Negative
Negative 2
Neutral 1

Recent News

Apr 10, 2026

The Ministry of Health has issued a directive to ensure a stable, timely, and reasonably priced supply of essential drugs, urging provinces, hospitals, and pharmaceutical companies to prevent shortages, hoarding, and unreasonable price increases while prioritizing domestic production.

↗ External source
7 Neutral

Multiple executives at Imexpharm sell shares citing personal financial adjustments; other transactions include Diamond Properties reducing NVL holdings, OCB insider sales, and foreign fund buying SHS shares.

↗ External source
6 Negative

Imexpharm (IMP) executives, including CEO Trần Thị Đào, registered to sell 607,400 shares (0.44% stake) from mid-April to mid-May 2026 for personal financial planning. The planned sales coincide with the company's annual meeting on April 22 and ambitious 2026 targets of VND 3,200B revenue (+9.8%) and VND 502B pre-tax profit (+12.6%).

insider trade Aveluro analysis
4 Negative

Related Stocks — Dược phẩm

DBD — Dược - Trang thiết bị y tế Bình Định DCL — Dược phẩm Cửu Long DHG — Dược Hậu Giang DMC — Xuất nhập khẩu Y tế Domesco LDP — Dược Lâm Đồng - Ladophar MED — Dược Trung ương Mediplantex TRA — Traphaco

Stock Analysis

Dược phẩm sector Recent News Dashboard

Information provided for educational purposes only. Past performance does not guarantee future results. Data sourced from public Vietnamese market feeds.

Last updated: 2026-04-19T13:36:58Z.